Pfost Dale R
CIK 0001394663
Chief Executive OfficerDirector
Filings
1
Latest Mar 15, 2022
Issuers covered
1
Showing
1 of 1
Page 1
Track record
2 of 2 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 100% | +2.3% | +2.3% | +2.3% | +2.3% |
| 90 days | 2 | 0% | -15.4% | -15.4% | -15.4% | -15.4% |
| 180 days | 2 | 0% | -13.4% | -13.4% | -13.4% | -13.4% |
| 365 days | 2 | 0% | -62.5% | -62.5% | -62.5% | -62.5% |
Issuers
Companies where Pfost Dale R has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| CMMB | Chemomab Therapeutics Ltd. | 1 | Mar 15, 2022 |
All filings
1 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|